CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.560
+0.090 (3.64%)
Dec 20, 2024, 4:00 PM EST - Market closed

CytoMed Therapeutics Market Cap

CytoMed Therapeutics has a market cap or net worth of $29.54 million as of December 20, 2024. Its market cap has decreased by -30.56% in one year.

Market Cap
29.54M
Enterprise Value
24.83M
1-Year Change
-30.56%
Ranking
Category
Stock Price
$2.56

Market Cap Chart

Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $29.54M, a decrease of -35.94%. That is a compound annual growth rate of -23.19%.

History

DateMarket Cap% Change
Dec 20, 202429.54M-47.71%
Dec 29, 202356.49M22.50%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Anebulo Pharmaceuticals 28.79M
IGC Pharma 28.50M
IRIDEX 28.45M
RAPT Therapeutics 28.24M
Calidi Biotherapeutics 28.01M
KALA BIO 27.66M
RenovoRx 27.58M
Forte Biosciences 27.28M
Market Cap Rankings